Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients

PURPOSE: This prospective clinical trial investigated sodium ((23)Na) MRI at 7 Tesla (T) field strength as biomarker for tumor extent, isocitrate dehydrogenase (IDH) mutation and O6-methylguanine DNA methyltransferase (MGMT) promotor methylation in glioma patients. METHODS: 28 glioma patients underw...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuroimage Clin
Main Authors: Regnery, Sebastian, Behl, Nicolas G.R., Platt, Tanja, Weinfurtner, Nina, Windisch, Paul, Deike-Hofmann, Katerina, Sahm, Felix, Bendszus, Martin, Debus, Jürgen, Ladd, Mark E., Schlemmer, Heinz-Peter, Rieken, Stefan, Adeberg, Sebastian, Paech, Daniel
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2020
Assuntos:
Regular Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527584/
https://ncbi.nlm.nih.gov/pubmed/33002860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nicl.2020.102427
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares